Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Ashwin Muruhadas"'
Autor:
Chee-Onn Leong, Malcolm F.G. Stevens, Tracey D. Bradshaw, Heng Lungh Choo, Nirmal Randhawa, Ashwin Muruhadas, Kai Hung Tiong, Boon Shing Tan
PDF file - 64K
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::26c0e9465ad4a531af2ba888341fb366
https://doi.org/10.1158/1535-7163.22496415.v1
https://doi.org/10.1158/1535-7163.22496415.v1
Autor:
Chee-Onn Leong, Malcolm F.G. Stevens, Tracey D. Bradshaw, Heng Lungh Choo, Nirmal Randhawa, Ashwin Muruhadas, Kai Hung Tiong, Boon Shing Tan
PDF file - 569K
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a74a6bf280570d8fd314b8501dcde481
https://doi.org/10.1158/1535-7163.22496412
https://doi.org/10.1158/1535-7163.22496412
Autor:
Chee-Onn Leong, Malcolm F.G. Stevens, Tracey D. Bradshaw, Heng Lungh Choo, Nirmal Randhawa, Ashwin Muruhadas, Kai Hung Tiong, Boon Shing Tan
Both 2-(4-amino-3-methylphenyl)-5-fluorobenzothiazole (5F-203; NSC 703786) and 2-(3,4-dimethoxyphenyl)-5-fluorobenzothiazole (GW-610; NSC 721648) are antitumor agents with novel mechanism(s). Previous studies have indicated that cytochrome (CYP) P450
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::26d3d3106604927bfb2cf8eff32dc1c6
https://doi.org/10.1158/1535-7163.c.6535263.v1
https://doi.org/10.1158/1535-7163.c.6535263.v1
Autor:
Chee-Onn Leong, Malcolm F.G. Stevens, Tracey D. Bradshaw, Heng Lungh Choo, Nirmal Randhawa, Ashwin Muruhadas, Kai Hung Tiong, Boon Shing Tan
PDF file - 55K
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::500294b0165133573b96dfd839e8e6b5
https://doi.org/10.1158/1535-7163.22496409.v1
https://doi.org/10.1158/1535-7163.22496409.v1
Autor:
Nirmal Randhawa, Chee-Onn Leong, Ashwin Muruhadas, Tracey D. Bradshaw, Heng Lungh Choo, Malcolm F. G. Stevens, Boon Shing Tan, Kai Hung Tiong
Publikováno v:
Molecular Cancer Therapeutics. 10:1982-1992
Both 2-(4-amino-3-methylphenyl)-5-fluorobenzothiazole (5F-203; NSC 703786) and 2-(3,4-dimethoxyphenyl)-5-fluorobenzothiazole (GW-610; NSC 721648) are antitumor agents with novel mechanism(s). Previous studies have indicated that cytochrome (CYP) P450
Autor:
Chee-Onn Leong, Boon Shing Tan, Kai Hung Tiong, Ashwin Muruhadas, Nirmal Randhawa, Heng Lungh Choo, Malcolm FG Stevens, Tracey D. Bradshaw
Publikováno v:
Molecular Cancer Therapeutics. 10:C75-C75
Phortress, the lysylamide prodrug of 2-(4-amino-3-methylphenyl)-5-fluorobenzothiazole (5F203, NSC 703786) is under clinical evaluation. CYP1A1-catalyzed bioactivation of 5F203 is crucial for antitumor activity. 2-(3,4-Dimethoxyphenyl)-5-fluorobenzoth